DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 173 filers reported holding DIPLOMAT PHARMACY INC in Q4 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $14,520,000 | -36.4% | 1,078,728 | -8.3% | 0.29% | -22.1% |
| Q3 2018 | $22,834,000 | -11.9% | 1,176,409 | +16.0% | 0.37% | -13.6% |
| Q2 2018 | $25,932,000 | +25.6% | 1,014,552 | -1.0% | 0.42% | +21.8% |
| Q1 2018 | $20,640,000 | +2.3% | 1,024,336 | +1.9% | 0.35% | +1.2% |
| Q4 2017 | $20,173,000 | -19.9% | 1,005,114 | -17.3% | 0.34% | -17.9% |
| Q3 2017 | $25,179,000 | +132.1% | 1,215,779 | +65.8% | 0.42% | +124.6% |
| Q2 2017 | $10,850,000 | -10.4% | 733,131 | -3.5% | 0.19% | -18.0% |
| Q1 2017 | $12,115,000 | +30.5% | 759,547 | +3.1% | 0.23% | +26.0% |
| Q4 2016 | $9,287,000 | -62.4% | 737,025 | -16.5% | 0.18% | -61.0% |
| Q3 2016 | $24,724,000 | -21.5% | 882,682 | -1.9% | 0.46% | -28.6% |
| Q2 2016 | $31,499,000 | +23.3% | 899,977 | -3.5% | 0.65% | +14.8% |
| Q1 2016 | $25,548,000 | -20.4% | 932,403 | -0.6% | 0.57% | -24.9% |
| Q4 2015 | $32,111,000 | +336.1% | 938,383 | +266.1% | 0.75% | +328.4% |
| Q3 2015 | $7,364,000 | – | 256,322 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 445,200 | $7,101,000 | 1.80% |
| Redmile Group, LLC | 1,254,342 | $20,007,000 | 1.30% |
| Irving Magee Investment Management | 166,505 | $2,656,000 | 1.02% |
| BROADVIEW ADVISORS LLC | 376,050 | $5,998,000 | 0.83% |
| Sivik Global Healthcare LLC | 101,000 | $1,611,000 | 0.75% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 5,455,461 | $87,015,000 | 0.64% |
| Iguana Healthcare Management, LLC | 75,000 | $1,196,000 | 0.59% |
| RIVERBRIDGE PARTNERS LLC | 1,464,286 | $23,355,000 | 0.47% |
| HERMES INVESTMENT MANAGEMENT LTD | 1,772,777 | $28,276,000 | 0.46% |
| Endurant Capital Management LP | 85,043 | $1,356,000 | 0.44% |